Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT00208416
Other study ID # CT02/29
Secondary ID
Status Terminated
Phase Phase 4
First received September 13, 2005
Last updated May 9, 2016
Start date October 2005
Est. completion date November 2014

Study information

Verified date March 2016
Source DePuy International
Contact n/a
Is FDA regulated No
Health authority United Kingdom: Medicines and Healthcare Products Regulatory Agency
Study type Interventional

Clinical Trial Summary

The purpose of this study is to compare the short-term outcomes of two surgical techniques, minimally invasive and conventional, when used in the treatment of patients with hip joint disease requiring a total hip replacement. Patients who enter the study will be randomly allocated to undergo surgery using the minimally invasive or conventional surgical technique and will be evaluated at regular intervals following hip surgery using patient, clinical and x-ray assessments with a focus on short term rehabilitation.


Recruitment information / eligibility

Status Terminated
Enrollment 58
Est. completion date November 2014
Est. primary completion date December 2007
Accepts healthy volunteers No
Gender Both
Age group 18 Years to 75 Years
Eligibility Inclusion Criteria:

i) Male or female subjects, aged between 18 and 75 years inclusive.

ii) Subjects who are able to give voluntary, written informed consent to participate in this investigation and from whom consent has been obtained.

iii) Subjects who in the opinion of the Investigator, are able to understand this investigation, co-operate with the investigational procedures and are willing to return to the hospital for all the required post-operative follow-ups.

iv) Subjects with a primary diagnosis of osteoarthritis.

v) Subjects considered suitable for a primary total hip arthroplasty and are considered suitable for a minimally invasive surgical procedure.

Exclusion Criteria:

i) Subjects who, in the opinion of the Investigator, have an existing condition that would compromise their participation and follow-up in this study, or extend their time to discharge beyond that required for their hip replacement surgery.

ii) Women who are pregnant.

iii) Subjects who are known drug or alcohol abusers or with psychological disorders that could effect follow-up care or treatment outcomes.

iv) Subjects who have participated in a clinical study with an investigational product in the last 6 month(s).

v) Subjects who are currently involved in any injury litigation claims.

vi) Subjects with a Body Mass Index (BMI) > 30.

vii) Subjects with a malunion, arthrodesis or severe dysplasia with superior femoral head migration.

viii) Subjects requiring a simultaneous bilateral total hip arthroplasty.

ix) Subjects undergoing the second stage of a staged bilateral who are less than 9 months post-arthroplasty

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Procedure:
DePuy MI System
A minimally invasive surgical technique used in total hip replacement.
Conventional surgical technique
A conventional surgical technique used in total hip replacement

Locations

Country Name City State
United Kingdom Rotherham General Hospitals NHS Trust Rotherham South Yorkshire
United Kingdom Warwick Hospital NHS Trust Warwick

Sponsors (1)

Lead Sponsor Collaborator
DePuy International

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Primary Number of hours post-operatively after which subjects are first able to mobilise with a frame or crutches First post-operative day No
Primary Level of assistance required to perform 3 functional tasks (supine to sit, sit to stand and bed to chair transfer)on the second post-operative day Second post-operative day No
Primary Time taken (in seconds) for subjects to walk 10 metres on the second post-operative day. Second post-operative day No
Primary Amount of time (in seconds) for which subjects are able to stand on the operative leg on the second post-operative day. Second post-operative day No
Secondary Haematological parameters assessed over a 56 hours post op 56 hours post-operatively No
Secondary Pain levels and wound condition Until discharge No
Secondary Trendelenberg sign Until discharge and at 6 weeks No
Secondary Day of discharge Until discharge No
Secondary Activity levels over specified distances Until discharge No
Secondary Harris Hip score 6 weeks, 6 months, 1 yr, 2 yrs, 5 yrs and 10 yrs post-surgery No
Secondary Oxford Hip score 6 weeks, 6 months, 1 yr, 2 yrs, 5 yrs and 10 yrs post-surgery No
Secondary Radiological analysis 6weeks, 6mths, 1yr, 2yrs, 5yrs and 10yrs post-surgery No